INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Integrated Single-Site CDMO Model

  A single‑site model reduces handoff risks, speeds timelines, strengthens quality oversight, and unifies development and manufacturing to improve reliability and execution efficiency.

• A Temperature-Stable Replacement For Animal Trypsin In Cell Dissociation Applications

  Improve cell dissociation with a gentle, recombinant enzyme. This temperature-stable protease shows dissociation kinetics similar to porcine trypsin but with lower cell toxicity and greater overall purity.

• GLP-1 INJ Solid Phase Peptide Synthesis (SPPS) Workflow

  Scale your GLP-1 peptide synthesis efficiently. Discover how automated solid-phase workflows and single-use fluidics maximize crude purity while reducing total solvent consumption.

• The Importance Of Quality In Raw Material Selection

  Learn how to select high-quality raw materials for cell-based manufacturing in this exploration of the criticality of raw materials, from preclinical development to commercialization. 

• Top Safety Considerations In Biopharmaceutical Manufacturing

  4/16/2025

  Understanding top safety concerns, from combustible material handling and chemical exposure to HPAPIs, is the first step toward preventing accidents in biopharmaceutical manufacturing environments.

• Building A Purification Toolkit For An Expanding Variety Of mAb Therapeutics

  5/29/2025

  Explore techniques for optimizing purification toolkits for various monoclonal antibody formats. This session covers resin and buffer selection for efficient downstream process development.

• Supply Resiliency For Bioprocessing Amid Global Volatility

  10/2/2025

  Build bioprocessing resiliency with strategic supply chain management. Learn to meet quality, compliance, and time-to-market demands amid global volatility with effective sourcing.

• The Crucial Role Of Cleaning In Effective VPHP Decontamination For Isolators

  12/27/2024

  Effective isolator cleaning is crucial for vapor phase hydrogen peroxide (VPHP) decontamination. Proper tools, techniques, and training ensure sterility, and regulatory compliance.

• Risk Mitigation For Late-Stage Clinical Assets

  6/11/2025

  Leveraging the competence and capabilities of the CDMO to bring forth innovative, flexible solutions to safeguard supply chains for their clients and, ultimately, for patients is crucial to strategic partnering.